CLN2 Disease Educational Webinar Series
THE IMPORTANCE OF EARLY GENETIC TESTING IN PEDIATRIC EPILEPSY
Insights from the CLN2 disease experience
Our expert international faculty will discuss compelling evidence on the importance of early genetic testing to understand seizure etiology in pediatric epilepsy patients.
You will learn about diagnostic testing options which could uncover the underlying cause of a seizure. A definitive diagnosis can enable more precise clinical management and improve patient outcomes, in some cases.
GOALS & STRATEGIES FOR MANAGING CLN2 DISEASE
Multidisciplinary care for this rapidly progressing paediatric neurodegenerative disorder
Our expert international faculty will discuss the CLN2 disease-specific management strategies that can greatly impact patient outcomes.
You will learn about how goals and interventions evolve as the disease progresses from maintaining function early in the disease, to maintaining quality of life later in the disease.
You will also learn about the roles of the multidisciplinary care team in the implementation of key management goals and strategies in clinical practice to improve patient outcomes.
No CME credit will be offered for these webinars
These webinars are developed and funded by BioMarin